grekovВестник хирургии имени И.И. ГрековаGrekov's Bulletin of Surgery0042-46252686-7370Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russion Federation, FSBEI HE I.P.Pavlov SPbSMU MOH Russia10.24884/0042-4625-2015-174-1-75-77grekov-18Research ArticleХИРУРГИЯ ЗА РУБЕЖОМSURGERY ABROADПОСТЛУЧЕВЫЕ СИАЛОЗОАДЕНИТЫ У ПАЦИЕНТОВ С ПАПИЛЛЯРНЫМИ КАРЦИНОМАМИ ЩИТОВИДНОЙ ЖЕЛЕЗЫPOSTRADIAL SIALOZOADENITIS IN PATIENTS WITH PAPILLARY CARCINOMA OF THE THYROID GLANDКоваленкоВ. А.KovalenkoV. A.tory.smile@bigmir.netКопчакА. В.KopchakA. V.kopchak@ua.fmКоваленкоА. Е.KovalenkoA. E.ae@kovalenko.co.uaИнститут эндокринологии и обмена веществ им. В. П. Комиссаренко НАМН УкраиныРоссияInstitute of endocrinology and metabolism named after V.P.KomissarenkoRussian Federation20152802201517417577Copyright © Коваленко В.А., Копчак А.В., Коваленко А.Е., 20152015Коваленко В.А., Копчак А.В., Коваленко А.Е.Kovalenko V.A., Kopchak A.V., Kovalenko A.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vestnik-grekova.ru/jour/article/view/18

The authors present the results of investigation of 42 patients with salivary gland dysfunction after radioactive iodine-131 ablation therapy concerning papillary thyroid carcinoma. Clinical manifestations of postradial sialodenitis with secretory insufficiency of different degree were revealed. These side effects required an application of the special therapy.

папиллярная карцинома щитовидной железытерапия радиоактивным131Iпостлучевой сиалозоаденитpapillary carcinoma of the thyroid glandradioactive iodine-131 ablation therapypostradial sialozoadenitisReferencesJeong S. Y., Kim H. W., Lee S. W. et al. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms // Thyroid. 2013. Vol. 23, № 5. P. 609-616.Jeong S. Y., Kim H. W., Lee S. W. et al. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms // Thyroid. 2013. Vol. 23, № 5. P. 609-616.Newkirk K. A., Ringel M. D., Wartofsky L., Burman K. D. The role of radioactive iodine in salivary gland dysfunction // Ear. Nose Throat. J. 2000. Vol. 79, № 6. P. 460-468.Newkirk K. A., Ringel M. D., Wartofsky L., Burman K. D. The role of radioactive iodine in salivary gland dysfunction // Ear. Nose Throat. J. 2000. Vol. 79, № 6. P. 460-468.Lee S. L. Complications of radioactive iodine treatment of thyroid carcinoma // J. Natl. Compr. Canc. Netw. 2010. Vol. 8, № 11. P. 1277-1286.Lee S. L. Complications of radioactive iodine treatment of thyroid carcinoma // J. Natl. Compr. Canc. Netw. 2010. Vol. 8, № 11. P. 1277-1286.Grewal R. K., Larson S. M., Pentlow C. E. et al. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation // J. Nucl. Med. 2009. Vol. 50, № 10. P. 1605-1610.Grewal R. K., Larson S. M., Pentlow C. E. et al. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation // J. Nucl. Med. 2009. Vol. 50, № 10. P. 1605-1610.

The authors declare that there are no conflicts of interest present.